A weight-management visit is not a generic visit. It isn't a therapy hour, an allied-health intake, or a primary-care annual. What sits in front of you is a longitudinal metabolic intervention with four moving parts: a dose ladder, a plateau curve, a side-effect profile, and a lifestyle-adherence layer. The chart has to model all four. If it doesn't, the clinician spends ten minutes of every visit doing math the software should be doing.
I've been talking to clinicians running medical weight-loss practices for the last six months. The same complaint keeps surfacing. They like their glp-1 clinic software the way you like a borrowed jacket: it covers the basics, but nothing fits. The titration ladder lives in their head. The side-effect history lives in three free-text fields across three notes. The plateau alert doesn't exist; they noticed it because they happened to look at the weight graph.
That's where this article starts. Not with the drug. With the chart.
The five visits that define a GLP-1 clinic
Most generalist EHRs treat every appointment like an island. A GLP-1 follow-up isn't an island. It's a station on a line, and here's what that line looks like in practice.
Intake — the metabolic baseline
BMI, waist circumference, comorbidities, prior weight-loss attempts, current medications (SSRIs, metformin, oral contraceptives), and screening for the contraindications that matter: personal or family history of medullary thyroid carcinoma, MEN2, prior pancreatitis. The chart needs to capture all of it as structured fields, not paragraph prose.
Initiation — first dose, first conversation
Starting dose decided, injection education delivered, side-effect expectations set, baseline labs ordered (lipids, HbA1c, LFTs, lipase if indicated). For semaglutide that's typically 0.25 mg weekly per the prescribing label. For tirzepatide it's 2.5 mg weekly. The chart needs to know which drug, which dose, which week.
Titration — climbing the ladder
This is where most generalist EHRs quietly fall apart. Semaglutide steps through 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg. Tirzepatide moves 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg. Every visit needs the prior dose, the current week on the ladder, the GI side-effect score, and the injection-site rotation pattern.
Plateau — the inflection that gets missed
Four weeks of flat weight on a stable dose is a clinical event. Most clinicians I've spoken with catch it by eyeballing the graph. The chart should be flagging it. Decisions at this point: hold the dose, intensify lifestyle work, consider dual therapy, or pause if tolerance has cracked.
The long game
Adherence support, weight-regain prevention, de-prescribing protocols. Lab cadence shifts. The visit cadence stretches. Most patients on these drugs will be on them for years, and the chart has to reason about a five-year arc, not a five-week one.
Five stations, five chart shapes. A generalist EHR gives you one note template and asks you to make it work everywhere.
What every metabolic chart should capture
A serious weight loss clinic ehr treats the following as first-class data, not free-text prose buried in a SOAP note.
A titration ladder that knows where the patient is on the schedule, and pre-populates the next visit's expected dose. A side-effect checklist with structured scoring (nausea 0–3, vomiting frequency, constipation, injection-site reactions), so a trend across four visits is a chart, not a memory test. A weight-trajectory graph that flags deviations automatically; four weeks without loss on a steady dose triggers a plateau alert. Injection-site rotation tracking, because patients miss this and lipohypertrophy patterns matter. Lifestyle-adherence capture (food logs, activity minutes, sleep) linked to the chart, not stored in some app the clinic can't see. Lab cadence reminders on drug-specific schedules: lipids and HbA1c on different windows than LFTs and lipase.
What does titration tracking actually mean in an EHR?
Titration tracking is the chart knowing where a patient sits on a structured dose schedule, what the next dose should be on what date, and which side effects or weight changes might pause the climb. For semaglutide and tirzepatide, that means the EHR carries the dose ladder, the week on the ladder, the GI tolerance scores, and any deviations, automatically populated from prior visits rather than retyped each time.
That's six categories. Six things a generalist tool will not capture without you building a workaround.
What this looks like as a chart
A metabolic dashboard at a glance: where the patient sits on the titration ladder, the weight trajectory with plateau detection, and the longitudinal side-effect log. None of these three live cleanly inside a generalist SOAP note.
What Jane, SimplePractice, and Carepatron offer instead
Honest answer: free-text SOAP fields and a date picker. Which is fine, if you're a counselor doing weekly therapy or a physio tracking a knee. It's not fine for a clinic running a four-month titration on twenty patients in parallel.
I sat in on a chart review with an obesity-medicine NP in Phoenix last month. She runs a cash-pay practice on a generalist allied-health platform she likes for everything except this. She had a spreadsheet open next to the EHR. The spreadsheet was the titration ladder. The EHR held the SOAP note. The patient's last lab came in by fax and lived as a PDF attachment. The plateau alert was her colleague saying, "hey, did you notice she's flat at 1.7?" in the hallway.
That's the workflow that loses ten minutes per visit. And it scales badly. Fifty patients, fifty mental titration ladders.
Here's the comparison, kept honest:
| GLP-1 chart need | Jane App | SimplePractice | Carepatron | Oli Health |
|---|---|---|---|---|
| Structured titration ladder | Free-text only | Free-text only | Free-text only | Native, drug-specific |
| Plateau detection (auto-flag) | Manual | Manual | Manual | AI-flagged at 4 weeks |
| Side-effect scoring (longitudinal) | Free-text only | Free-text only | Free-text only | Structured, charted |
| Injection-site rotation | None | None | None | Built into visit form |
| Weight-trajectory graph | Limited | Limited | Limited | Native, with alerts |
| Lab cadence reminders | Generic | Generic | Generic | Drug-specific schedule |
| Lifestyle adherence link | Manual upload | Manual upload | Manual upload | In-chart capture |
| AI patient overview pre-visit | None | Add-on, $35/mo | Token-capped on free | Included, $19.95/mo flat |
A generalist EHR gives you a notes field where a metabolic workflow should be. The clinician fills the gap. The clinician is the integration layer.
The AI-first argument: why titration belongs in the software, not your head
If you've read anything I've written before, you know I'm cautious about AI claims in healthcare software. Most "AI EHR" marketing is autocomplete with a haircut. So I want to be specific about what changes when the chart is built AI-first for metabolic care.
The software learns the titration ladder from the first prescription. Visit 1 logs 0.25 mg semaglutide on a Tuesday. The system already knows the next four weeks of expected doses, the week-by-week side-effect script to ask about, and the lab schedule. Visit 2 doesn't ask the clinician to remember. The chart pre-loads.
Weight trajectory is another place this lives. Manual graphs are fine until you have forty active patients. An AI-flagged plateau ("patient X has been within 0.4 kg of her current weight for 31 days on a stable 1.7 mg dose, consider plateau review") turns a missed inflection into a scheduled decision. I watched a physician in Calgary last quarter catch three plateau patients in a single week because the chart flagged what her eye would have rotated past.
Then there's pre-visit synthesis. An AI patient overview reads the entire metabolic history before a follow-up (every dose change, every side-effect score, every weight, every lab) and produces a one-page synthesis the clinician opens at the start of the visit. Not a scroll-through. A summary. The framing this gives a 15-minute follow-up is hard to overstate; you walk in already calibrated to the patient.
I should say something about privacy before I move on, because it's the question I get most. The AI overview operates inside the chart, on data the clinician already controls. Nothing leaves the practice's environment, and every chart edit stays under the clinician's signature. It saves time. It does not move authority.
Can Jane App or SimplePractice handle a GLP-1 workflow?
They can hold the notes. They can't model the workflow. Both platforms are excellent generalist tools for therapy and allied-health practice management, but neither has structured titration ladders, automatic plateau detection, longitudinal side-effect scoring, or drug-specific lab cadence reminders. A GLP-1 clinic running on a generalist EHR ends up rebuilding the metabolic workflow in spreadsheets, paper, and clinician memory.
BALANCE is coming, and the unprepared get caught
Most weight-management clinics today run cash-pay. That changes in May 2026, when the CMS BALANCE model begins rolling out Medicaid coverage of GLP-1s for chronic weight management. Medicare Part D follows in January 2027. A Medicare Bridge demonstration sits between them, slated for July 2026.
I've been thinking about this from the documentation side, not the policy side. Coverage rollouts are eligibility-tracking events. They are documentation-standard events. The clinics that win the next 18 months are the ones whose software handles BALANCE eligibility checks, prior auth flows, and plan-specific labs from day one. Not as an upgrade. As a default.
A generalist EHR can be patched to do this. Patched is the word. The patches usually cost extra, ship late, and don't talk to each other. A clinic that starts on a metabolic-aware platform now is six months ahead of one that starts in October.
This is the first of three pieces I'm putting together on the GLP-1 stack. Day 7 walks through a BALANCE readiness checklist: what to verify in your software, your forms, and your billing flow before May. Day 8 is a chart walkthrough, with real screens and real fields, showing what a metabolic visit looks like inside an AI-first EHR.
If the workflow gap I've described above sounds like your clinic, follow along for the next two posts. We'll get specific.
Frequently asked questions
What is a GLP-1 clinic?
A GLP-1 clinic is a medical weight-loss practice that prescribes glucagon-like peptide-1 receptor agonists (semaglutide, tirzepatide, liraglutide) for chronic weight management. Visits are structured around dose titration, side-effect monitoring, weight-trajectory tracking, and longitudinal lifestyle support. The model is closer to chronic-disease management than episodic primary care.
Do I need a specialty EHR for a weight-loss clinic, or can I use a generalist EHR?
You can technically run a weight-loss clinic on a generalist EHR. Many do. The cost is hidden: clinician time spent rebuilding the metabolic workflow in spreadsheets and notes, missed plateau inflections, and side-effect trends that never coalesce into a chart. A specialty or AI-first EHR with native titration tracking, plateau alerts, and drug-specific lab cadence saves roughly 10 minutes per visit and reduces the cognitive load of running the practice.
What does titration tracking actually mean in an EHR?
It means the chart carries the dose ladder for the patient's specific drug, knows the patient's current week on that ladder, pre-populates the expected next dose, and flags deviations like slow titration due to nausea, dose holds, or skipped weeks. For semaglutide that ladder is 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg weekly, per the prescribing label. The EHR should treat this as structured data, not free-text prose.
How does CMS BALANCE affect GLP-1 clinics?
BALANCE is the CMS Innovation Center model that begins covering GLP-1s for chronic weight management under Medicaid in May 2026, with Medicare Part D coverage following in January 2027. A Medicare Bridge demonstration is slated for July 2026. The practical effect for clinics: eligibility tracking, prior authorization flows, and plan-specific documentation become daily operational tasks. Software that handles these as defaults will run smoother than software that bolts them on later.
Can Jane App or SimplePractice handle a GLP-1 workflow?
For the SOAP note itself, yes. For the metabolic workflow around it (titration ladders, plateau alerts, longitudinal side-effect scoring, drug-specific lab cadence, BALANCE eligibility tracking), no. Both Jane and SimplePractice are generalist allied-health and behavioural-health platforms. They were not built for chronic metabolic management, and a clinic running this workflow at scale will hit the limits within the first 30 patients.
If your clinic is treating GLP-1 patients on a generalist EHR and the spreadsheet beside the chart is starting to feel permanent, Oli Health's metabolic workflow is worth a look. Flat $19.95/mo, AI patient overview included, titration tracking built in. The next two pieces in this series will go deeper into what that looks like inside the chart.
